Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Talasz

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
International Journal of Clinical Pharmacology and Therapeutics|December 24, 2010
MRI Molecular imaging with albumin nanoparticles: achievements and challengesG C Thurner, A A Abdelmoez, E A Wallnoefer, et al.
Histochemistry and Cell Biology|July 15, 2010
Albumin-based nanoparticles as magnetic resonance contrast agents: II. Physicochemical characterisation of purified and standardised nanoparticlesA A Abdelmoez, G C Thurner, E A Wallnöfer, et al.
Histochemistry and Cell Biology|October 11, 2020
Albumin-based nanoparticles as contrast medium for MRI: vascular imaging, tissue and cell interactions, and pharmacokinetics of second-generation nanoparticlesE A Wallnöfer, G C Thurner, C Kremser, et al.
The Prostate|March 1, 1996
Inhibitory effects of the nucleoside analogue gemcitabine on prostatic carcinoma cellsM V Cronauer, H Klocker, H Talasz, et al.
Histochemistry and Cell Biology|February 23, 2010
Albumin-based nanoparticles as magnetic resonance contrast agents: I. Concept, first syntheses and characterisationM M Stollenwerk, I Pashkunova-Martic, C Kremser, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
International Journal of Clinical Pharmacology and Therapeutics|December 24, 2010
MRI Molecular imaging with albumin nanoparticles: achievements and challengesG C Thurner, A A Abdelmoez, E A Wallnoefer, et al.
Histochemistry and Cell Biology|July 15, 2010
Albumin-based nanoparticles as magnetic resonance contrast agents: II. Physicochemical characterisation of purified and standardised nanoparticlesA A Abdelmoez, G C Thurner, E A Wallnöfer, et al.
Histochemistry and Cell Biology|October 11, 2020
Albumin-based nanoparticles as contrast medium for MRI: vascular imaging, tissue and cell interactions, and pharmacokinetics of second-generation nanoparticlesE A Wallnöfer, G C Thurner, C Kremser, et al.
The Prostate|March 1, 1996
Inhibitory effects of the nucleoside analogue gemcitabine on prostatic carcinoma cellsM V Cronauer, H Klocker, H Talasz, et al.
Histochemistry and Cell Biology|February 23, 2010
Albumin-based nanoparticles as magnetic resonance contrast agents: I. Concept, first syntheses and characterisationM M Stollenwerk, I Pashkunova-Martic, C Kremser, et al.
Pageof 3